跳至主要内容
临床试验/NL-OMON21698
NL-OMON21698已完成不适用

The effect of Beta-Adrenergic receptor blockade on sympathetic activity and Coagulation in patients with Heart failure (BACH-F study).

P.W. Kamphuisen, internist, Vasculair Geneeskundige.0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Between 18 and 80 years of age, competent and willing of giving informed consent;
  • 2. With stable symptoms of chronic heart failure (NYHA II-III);

排除标准

  • 1. With a history of adverse reaction on beta-blockers;
  • 2. With a contraindication to â-blocker therapy (Sick-sinussyndrome, second and third AV-block), severe hypotension (systolic blood pressure < 100 mm Hg), cardiogenous shock, clinical relevant sinusbradycardia. Asthma, COPD. Liverfunctiondisorder (defined as elevation of aspartamine transaminase, alanine transaminase or bilirubin levels more than three times upper limit of normal range), renal disease (calculated creatinine clearance <50ml/min, using Cockcroft¡¯s formula). Insulin dependent diabetes mellitus.);

研究者

发起方
P.W. Kamphuisen, internist, Vasculair Geneeskundige.

相似试验